Investment analysts and portfolio managers look into their crystal balls to predict the best-performing stocks for the year ahead.
The cervical cancer screening device company has lifted sales despite Covid disruption.
The honey company went into a trading halt to clear up market speculation.
Restaurant owner says it is already trading above 2019 levels.
Sensor company targets growth in chip-making segment after product improvements.
The NY-based mega fund manager has deep pockets and an interest in NZ.
Rapidly escalating cost pressures to push prices up.
Probiotics seller says drop in ingredients segment sales drove result.
Joint supplement turned retirement company wants to carve niche serving higher-needs residents.
Walsh will sell off some of his shares.
